Skip to content
Screener

ResMed Inc. RMD Q4 2025 Annual earnings

Reported July 31, 2025 · After market close

Revenue$1.3BIn line
EPS$2.55In line
Revenue estimate$1.3B
EPS estimate$2.55

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.4B
EPS estimate$2.69

Financials

Q4 2025

Income statement

See full
Revenue$1.3B+10.2%
Gross profit$820.1M+14.6%
Operating income$454.5M+19.2%
Net income$379.7M+29.9%
EPS (diluted)$2.58+30.3%

Balance sheet

See full
Cash & equivalents$1.2B+407%
Total debt$861.7M-2.5%
Total equity$6.0B+22.7%
Total assets$8.2B+18.9%

Cash flow

See full
Operating cash flow$538.8M+22.4%
CapEx$30.6M+22.9%
Free cash flow$508.2M+22.4%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$37.52B+33.4%
Enterprise value$37.18B+29.2%
P/E26.8×-0.8×
P/S7.3×+1.3×

Profitability

See full
Gross margin59.4%+2.7pp
Operating margin32.7%+4.6pp
Net margin27.2%+5.4pp
FCF margin32.3%+4.5pp

Returns & leverage

See full
Return on equity25.9%+3.2pp
Debt / equity0.1×0.0×
Current ratio3.4×+0.9×

Segments

By segment

See full
Sleep and Breathing Health$1.2B—
Residential Care Software$167.0M—

By product

See full
Sleep and Breathing Health$1.2B—
Residential Care Software$167.0M—

FAQ

When did ResMed Inc. report Q4 2025 earnings?
ResMed Inc. (RMD) reported Q4 2025 earnings on July 31, 2025 after market close.
What were ResMed Inc.'s Q4 2025 revenue and EPS?
ResMed Inc. reported revenue of $1.3B and eps of $2.55 for Q4 2025.
Did ResMed Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.3B by -. EPS beat the consensus estimate of $2.55 by $0.00.
How did ResMed Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.2% from $1.2B a year earlier and eps grew 22.6% from $2.08.
Where can I find ResMed Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-170512) and the 10-K periodic report (0000943819-25-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.